Delivery Order SPE2DB20D3103-SPE2DB25FP6D1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive procurement for a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,357.62 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, an ergot alkaloid medication used primarily in obstetric settings. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,991.60 with a firm fixed price for the supply of 4563358199 - Methylergonovine 0.2 mg/mL vials. The contract has an ultimate completion date of January 19, 2024 and was awarded on January 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.20, is for the delivery of 4568112775 methylergonovine 0.2 mg tablets. The contract has a period of performance through May 5, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Methylergon 0.2mg in a 12-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,142.49 and has an ultimate completion date of July 22, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside provisions were utilized for this award,...
- This federal contract award is a delivery order valued at $3,589.92 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, was awarded by the Defense Logistics Agency (DLA) and involves the delivery of METHYLERGONOVINE 0.2 MG/ML medication with an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,209.24 firm fixed-price contract is for the supply of methylergonovine 0.2 mg/ml ampompoules, a prescription medication. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to...
- The Defense Logistics Agency Troop Support Medical awarded a $1,144.77 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 0.2 mg/ml vials of methylergonovine under contract number 4561598047. Performance will take place in Conshohocken, Pennsylvania over one day from July 25 to July 26, 2023. Amerisourcebergen Corporation, the parent company of Amerisourcebergen Drug Corporation, will serve as the prime contractor to supply this pharmaceutical product in support of the...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product. The award has a completion date of February 5, 2024 and a potential value of $7,083.54. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp, as the prime contractor, has received numerous previous awards from DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,846.48 Firm Fixed Price Delivery Order is for the supply of 4,565,116,351 methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other federal healthcare programs....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6D1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,555.82 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. The contract is a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. This award carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's performance on such delivery orders demonstrates its capability to fulfill federal medical supply requirements through the DLA's pharmaceutical supply chain, supporting critical healthcare needs across the Department of Defense and related federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/23/25 |